Inventor
ZAGURY JEAN-FRANCOIS
FR23 patents
⚠️ This page may combine multiple inventors who share the name “ZAGURY JEAN-FRANCOIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEOVACS
9 patentsUS6093405AJul 25, 2000
Inactive but immunogenic cytokines, pharmaceutical compositions containing same, and methods of treating homeostatic disorders associated with an overproduction of cytokines
NEOVACS55 citations95
US6132721AOct 17, 2000
Non-Toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same
NEOVACS20 citations92
US6420141B1Jul 16, 2002
Anti-HIV immunogens (toxoids), preparation methods and use for preventing and treating aids
NEOVACS17 citations88
US6200575B1Mar 13, 2001
Non-toxic immunogens derived from a retroviral regulatory protein antibodies preparation process and pharmaceutical compositions comprising them
NEOVACS18 citations83
US7022482B2Apr 4, 2006
Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses
NEOVACS14 citations79
US6878370B1Apr 12, 2005
Chemically modified TNF-α
NEOVACS7 citations73
US6455045B1Sep 24, 2002
Immunogenic compounds with in particular an anti-cytokine effect, preparation process, pharmaceutical compositions and kits containing them
NEOVACS13 citations73
US7022326B1Apr 4, 2006
Carboxymethylated retroviral regulatory proteins and interferon-α
NEOVACS9 citations69
US7504479B2Mar 17, 2009
Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses
NEOVACS0 citations47
ZAGURY JEAN-FRANCOIS
5 patentsUS8975399B2Mar 10, 2015
Benzenesulfon amide-compound treatment of a pathological condition linked to an excessive effect of TNF
ZAGURY JEAN-FRANCOIS5 citations61
US8529881B2Sep 10, 2013
Peptides for active anti-cytokine immunization
ZAGURY JEAN-FRANCOIS0 citations51
US8277792B2Oct 2, 2012
Peptides for active anti-cytokine immunization
ZAGURY JEAN-FRANCOIS0 citations51
US8147819B2Apr 3, 2012
Peptides for active anti-cytokine immunization
ZAGURY JEAN-FRANCOIS0 citations51
US8632781B2Jan 21, 2014
Immunogenic compounds comprising peptides of IL1β
ZAGURY JEAN-FRANCOIS0 citations38
VAXCONSULTING
4 patentsUS7892558B2Feb 22, 2011
Isolated TNF-alpha peptide and pharmaceutical composition thereof
VAXCONSULTING12 citations82
US7393523B2Jul 1, 2008
Peptides for active anti-cytokine immunization
VAXCONSULTING1 citations61
US7892529B2Feb 22, 2011
Peptides for active anti-cytokine immunization
VAXCONSULTING0 citations50
US7641895B2Jan 5, 2010
Peptides for active anti-cytokine immunization
VAXCONSULTING0 citations50